A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.
SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results